Japanese authorities suspended another one million doses of Moderna’s COVID-19 vaccine on Aug. 29 at distribution centers in two regions over contamination concerns, according to the local governments. The latest suspension came a day after officials reported that two men in their 30s died after receiving doses from other tainted Moderna lots placed under investigation—around 1.63 million…
Japan Suspends Another 1 Million Moderna Doses Over Contamination Concerns
Two Men Die After Getting Moderna Jab From ‘Contaminated Batch’ in Japan
Two people have died in Japan after receiving Moderna’s COVID-19 vaccine amid an ongoing investigation into reports of contamination related to three batches of vaccines that amount to 1.63 million doses, the country’s health ministry said on Saturday. Both men, in their 30s, died in August within days of receiving their second dose of the…
Moderna Vaccine Production Continues in Spain Amid Contamination Probe: EMA
The European Medicine Agency (EMA) has instructed a Spanish plant on Friday to continue producing Moderna’s COVID-19 vaccine after about 1.63 million doses got suspended due to reports of contamination. Earlier this week, the Japanese Ministry of Health said they received information that “foreign materials” were found in at least 390 doses—or 39 vials—of the…
Moderna Finishes Application for COVID-19 Vaccine Approval
Moderna said Wednesday its finished its application to drug regulators for approval for its COVID-19 vaccine. “This BLA submission for our COVID-19 vaccine, which we began in June, is an important milestone in our battle against COVID-19 and for Moderna, as this is the first BLA submission in our company’s history,” Stéphane Bancel, Moderna’s CEO,…
Vaccines Doesn’t Reduce Peak Viral Load When Infected With Delta Variant, UK Study Suggests
Those who caught the Delta Variant of the CCP virus after being fully vaccinated carry a similar level of peak viral burden with their unvaccinated counterparts, a new UK analysis suggests. This suggests that a vaccinated and an unvaccinated individual, while infected with the variant, would shed similar amounts of the virus at any given time…
With Delta Variant, Vaccines Don’t Reduce Peak Viral Load: UK Study
Those who caught the Delta Variant of the CCP virus after being fully vaccinated carry a similar level of peak viral burden with their unvaccinated counterparts, a new UK analysis suggests. This suggests that a vaccinated and an unvaccinated individual, while infected with the variant, would shed similar amounts of the virus at any given time…
Pfizer-BioNTech and Moderna Poised to Make Billions on COVID-19 Boosters
Moderna and the Pfizer-BioNTech alliance could reap billions from COVID-19 booster shots in the coming years, in what analysts and investors say could be a market comparable to the $6 billion in annual sales for flu vaccines. Pfizer, its German partner BioNTech, and Moderna have together locked in over $60 billion in sales of their…
Effectiveness of Some COVID-19 Vaccines Has Dropped Significantly: Study
The effectiveness of the two most widely used COVID-19 vaccines in the United States dropped significantly in July, a new study found. The efficacy of shots from Moderna and Pfizer were highly effective in preventing transmission of the CCP (Chinese Communist Party) virus, which causes COVID-19, between January and June, researchers with the Mayo Clinic and Massachusetts-based nference…
Australia Approves Moderna’s COVID-19 Vaccine as Lockdowns Expand
A third brand of COVID-19 vaccines will soon become available for adults in Australia, with one million doses expecting to arrive for distribution next month, the government announced on Monday. Prime Minister Scott Morrison said in a press release that the country’s vaccine regulator, Therapeutic Goods Administration (TGA), has approved the Moderna shot and that 25…
Moderna on Its Way to Australia in September: Health Minister
Australian Health Minister Greg Hunt has promised that millions of doses of another mRNA COVID-19 vaccine by Moderna will be available in coming months, as the nation continues seeing public preference for mRNA vaccines shaped by initial caution over reports of blood clot deaths among AstraZeneca vaccine recipients. In Australia, mRNA vaccines are in limited supply, while…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`